Company intelligence / Profile preview

LYFE Capital

Shanghai, Shanghai, Chinalyfecapital.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

LYFE Capital is a leading healthcare-focused venture capital and private equity investment platform with global reach. It specializes in investing in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, and digital health companies. The firm has supported multiple portfolio companies through IPOs and trade sales on major exchanges such as NASDAQ and Hong Kong Stock Exchange.

Industry: Investors

Partnerships

Global pharma leaders (via portfolio companies)GSK (via portfolio company ST Pharm)Novartis (via portfolio company ST Pharm)Roche (via portfolio company ST Pharm)

Beyond the preview

Go deeper on LYFE Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LYFE Capital.

Explore the full profile